GB1487842A - Prostenoic acids and process for their manufacture - Google Patents
Prostenoic acids and process for their manufactureInfo
- Publication number
- GB1487842A GB1487842A GB40536/74A GB4053674A GB1487842A GB 1487842 A GB1487842 A GB 1487842A GB 40536/74 A GB40536/74 A GB 40536/74A GB 4053674 A GB4053674 A GB 4053674A GB 1487842 A GB1487842 A GB 1487842A
- Authority
- GB
- United Kingdom
- Prior art keywords
- denotes
- symbols
- formula
- compounds
- hydroxy group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 2
- 238000006228 Dieckmann condensation reaction Methods 0.000 abstract 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 238000006114 decarboxylation reaction Methods 0.000 abstract 1
- 238000005661 deetherification reaction Methods 0.000 abstract 1
- 229910052987 metal hydride Inorganic materials 0.000 abstract 1
- 150000004681 metal hydrides Chemical class 0.000 abstract 1
- 229930014626 natural product Natural products 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000003033 spasmogenic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732346706 DE2346706A1 (de) | 1973-09-17 | 1973-09-17 | Neue, nicht natuerlich vorkommende analoga von prostansaeuren und verfahren zu ihrer herstellung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1487842A true GB1487842A (en) | 1977-10-05 |
Family
ID=5892789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB40536/74A Expired GB1487842A (en) | 1973-09-17 | 1974-09-17 | Prostenoic acids and process for their manufacture |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4078083A (enExample) |
| JP (1) | JPS585195B2 (enExample) |
| AT (1) | AT355234B (enExample) |
| AU (1) | AU502576B2 (enExample) |
| BE (1) | BE820008A (enExample) |
| CA (1) | CA1036157A (enExample) |
| CH (1) | CH609970A5 (enExample) |
| DE (1) | DE2346706A1 (enExample) |
| DK (1) | DK487474A (enExample) |
| ES (1) | ES429959A1 (enExample) |
| FR (1) | FR2243689B1 (enExample) |
| GB (1) | GB1487842A (enExample) |
| HU (1) | HU173876B (enExample) |
| IL (1) | IL45678A0 (enExample) |
| NL (1) | NL7412117A (enExample) |
| SE (1) | SE7411664L (enExample) |
| ZA (1) | ZA745912B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002042268A3 (en) * | 2000-11-27 | 2002-07-25 | Pfizer Prod Inc | Ep4 receptor selective agonists in the treatment of osteoporosis |
| WO2004037813A1 (en) * | 2002-10-25 | 2004-05-06 | Merck Frosst Canada & Co. | Pyrrolidin-2-on derivatives as ep4 receptor agonists |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2426853A1 (de) * | 1974-06-04 | 1976-01-02 | Hoechst Ag | Neue cyclopentanderivate und verfahren zu ihrer herstellung |
| DE2628564A1 (de) * | 1976-06-25 | 1978-01-05 | Hoechst Ag | Ester von 5-methyl-10,11-dihydroprostaglandin-a tief 1 |
| US4254145A (en) * | 1978-08-16 | 1981-03-03 | American Cyanamid Company | Topical application of prostaglandin hypotensive agents |
| DE3029984C2 (de) * | 1980-08-08 | 1983-12-15 | Grünenthal GmbH, 5190 Stolberg | 2-Oxabicyclo [3.3.0] octanderivate und diese enthaltende Arzneimittel |
| DE3832985A1 (de) * | 1988-09-29 | 1990-04-05 | Renk Ag | Einrichtung zum verarbeiten und drahtlosen senden von messwerten |
| US20080015219A1 (en) * | 2006-07-11 | 2008-01-17 | Allergan, Inc. | Therapeutic compounds |
| AU2007272617B2 (en) * | 2006-07-11 | 2012-11-01 | Allergan, Inc. | Cyclopentane derivatives as antiglaucoma agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3870747A (en) * | 1971-11-24 | 1975-03-11 | Merck & Co Inc | Intermediates and process for prostaglandin synthesis |
| US3873607A (en) * | 1972-07-24 | 1975-03-25 | American Cyanamid Co | 3-Oxa(and thia) 11-deoxy PGE |
| JPS4995941A (enExample) * | 1973-01-27 | 1974-09-11 |
-
1973
- 1973-09-17 DE DE19732346706 patent/DE2346706A1/de not_active Withdrawn
-
1974
- 1974-09-07 ZA ZA00745912A patent/ZA745912B/xx unknown
- 1974-09-11 ES ES0429959A patent/ES429959A1/es not_active Expired
- 1974-09-12 NL NL7412117A patent/NL7412117A/xx not_active Application Discontinuation
- 1974-09-12 CH CH1243774A patent/CH609970A5/xx not_active IP Right Cessation
- 1974-09-16 CA CA209,315A patent/CA1036157A/en not_active Expired
- 1974-09-16 AU AU73333/74A patent/AU502576B2/en not_active Expired
- 1974-09-16 DK DK487474A patent/DK487474A/da unknown
- 1974-09-16 IL IL45678A patent/IL45678A0/xx unknown
- 1974-09-16 HU HU74HO1720A patent/HU173876B/hu unknown
- 1974-09-16 AT AT746674A patent/AT355234B/de not_active IP Right Cessation
- 1974-09-17 JP JP49107057A patent/JPS585195B2/ja not_active Expired
- 1974-09-17 FR FR7431396A patent/FR2243689B1/fr not_active Expired
- 1974-09-17 GB GB40536/74A patent/GB1487842A/en not_active Expired
- 1974-09-17 BE BE148609A patent/BE820008A/xx unknown
- 1974-09-17 SE SE7411664A patent/SE7411664L/xx unknown
-
1976
- 1976-02-19 US US05/659,239 patent/US4078083A/en not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002042268A3 (en) * | 2000-11-27 | 2002-07-25 | Pfizer Prod Inc | Ep4 receptor selective agonists in the treatment of osteoporosis |
| US6552067B2 (en) | 2000-11-27 | 2003-04-22 | Pfizer Inc. | EP4 receptor selective agonists in the treatment of osteoporosis |
| US6747054B2 (en) | 2000-11-27 | 2004-06-08 | Pfizer Inc. | EP4 receptor selective agonists in the treatment of osteoporosis |
| US7192979B2 (en) | 2000-11-27 | 2007-03-20 | Pfizer Inc. | EP4 receptor selective agonist in the treatment of osteoporosis |
| WO2004037813A1 (en) * | 2002-10-25 | 2004-05-06 | Merck Frosst Canada & Co. | Pyrrolidin-2-on derivatives as ep4 receptor agonists |
Also Published As
| Publication number | Publication date |
|---|---|
| ES429959A1 (es) | 1977-02-01 |
| AU7333374A (en) | 1976-03-18 |
| IL45678A0 (en) | 1974-11-29 |
| CH609970A5 (en) | 1979-03-30 |
| AT355234B (de) | 1980-02-25 |
| HU173876B (hu) | 1979-09-28 |
| AU502576B2 (en) | 1979-08-02 |
| DK487474A (enExample) | 1975-05-20 |
| ZA745912B (en) | 1975-10-29 |
| SE7411664L (enExample) | 1975-03-18 |
| ATA746674A (de) | 1979-07-15 |
| FR2243689B1 (enExample) | 1978-06-30 |
| FR2243689A1 (enExample) | 1975-04-11 |
| JPS585195B2 (ja) | 1983-01-29 |
| JPS5053352A (enExample) | 1975-05-12 |
| DE2346706A1 (de) | 1975-04-03 |
| BE820008A (fr) | 1975-03-17 |
| CA1036157A (en) | 1978-08-08 |
| NL7412117A (nl) | 1975-03-19 |
| US4078083A (en) | 1978-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2471963B1 (fr) | Procede de production d'une composition d'un catalyseur pour la synthese du methanol a basse temperature, catalyseur a utiliser et procede de production de methanol | |
| ES448454A1 (es) | Procedimiento para la preparacion de esteres dialcohilicos de acido malonico. | |
| ES8306105A1 (es) | Un metodo para producir isetionato de acilo. | |
| GB1487842A (en) | Prostenoic acids and process for their manufacture | |
| GB1313646A (en) | Process for producing 3-phenyl pentenals | |
| GB1384471A (en) | Process for the manufacture of fatty acid ethanolamides | |
| GR3022346T3 (en) | Process for producing sclareolide. | |
| ES8601841A1 (es) | Procedimiento para la obtencion de un ester de alquilo de c2+ primario de un acido carboxilico de alquilo | |
| KR840001530A (ko) | 분산제 조성물 | |
| JPS5599194A (en) | Production of aldonic acid by enzyme method | |
| JPS6471844A (en) | 2,4,5-trifluoroisophthalonitrile and production thereof | |
| GB1165309A (en) | Process for the preparation of Higher Aliphatic Alcohols | |
| JPS5423607A (en) | Production of metallic soap | |
| JPS5214716A (en) | Process for preparation of alkali metlalformates | |
| JPS5373529A (en) | Preparation of hydroquinone | |
| KR860003191A (ko) | 에틸렌 옥사이드 부가물의 제조방법 | |
| GB1464418A (en) | Production of 2-hydroxynaphthalene-3-carboxylic acid | |
| SU647300A1 (ru) | Способ получени 2-метил-3,4,6гептатриенола-2 | |
| JPS53119820A (en) | Preparation of alkali aminodiacetate | |
| JPS525692A (en) | Production process of catalyst for asymmetric hydrogenation | |
| JPS55111459A (en) | Preparation of cysteamine | |
| JPS5214715A (en) | Process for preparation of alkali metalformates | |
| JPS5533460A (en) | Cis-3-hexene derivative | |
| JPS549204A (en) | Preparation of aminocarboxylic acid ester of secondary or tertiary alcohol | |
| SU1098209A1 (ru) | Способ получения диэтилкетона |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |